X4 Pharmaceuticals Statistics
Total Valuation
XFOR has a market cap or net worth of $402.77 million. The enterprise value is $246.31 million.
Important Dates
The last earnings date was Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XFOR has 90.92 million shares outstanding. The number of shares has increased by 968.53% in one year.
| Current Share Class | 90.92M |
| Shares Outstanding | 90.92M |
| Shares Change (YoY) | +968.53% |
| Shares Change (QoQ) | +13.32% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 63.32% |
| Float | 64.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 44.68 |
| Forward PS | 48.95 |
| PB Ratio | 2.48 |
| P/TBV Ratio | 2.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 27.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.18, with a Debt / Equity ratio of 0.46.
| Current Ratio | 10.18 |
| Quick Ratio | 9.88 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.30 |
Financial Efficiency
Return on equity (ROE) is -104.21% and return on invested capital (ROIC) is -804.49%.
| Return on Equity (ROE) | -104.21% |
| Return on Assets (ROA) | -28.34% |
| Return on Invested Capital (ROIC) | -804.49% |
| Return on Capital Employed (ROCE) | -36.81% |
| Weighted Average Cost of Capital (WACC) | 6.47% |
| Revenue Per Employee | $200,311 |
| Profits Per Employee | -$2.22M |
| Employee Count | 45 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 0.42 |
Taxes
In the past 12 months, XFOR has paid $7,000 in taxes.
| Income Tax | 7,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.73% in the last 52 weeks. The beta is 0.32, so XFOR's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +36.73% |
| 50-Day Moving Average | 4.07 |
| 200-Day Moving Average | 3.57 |
| Relative Strength Index (RSI) | 58.13 |
| Average Volume (20 Days) | 364,176 |
Short Selling Information
The latest short interest is 3.14 million, so 3.46% of the outstanding shares have been sold short.
| Short Interest | 3.14M |
| Short Previous Month | 3.12M |
| Short % of Shares Out | 3.46% |
| Short % of Float | 4.87% |
| Short Ratio (days to cover) | 7.27 |
Income Statement
In the last 12 months, XFOR had revenue of $9.01 million and -$99.72 million in losses. Loss per share was -$1.38.
| Revenue | 9.01M |
| Gross Profit | 7.38M |
| Operating Income | -90.75M |
| Pretax Income | -99.72M |
| Net Income | -99.72M |
| EBITDA | -89.72M |
| EBIT | -90.75M |
| Loss Per Share | -$1.38 |
Full Income StatementBalance Sheet
The company has $233.72 million in cash and $77.25 million in debt, with a net cash position of $156.47 million or $1.72 per share.
| Cash & Cash Equivalents | 233.72M |
| Total Debt | 77.25M |
| Net Cash | 156.47M |
| Net Cash Per Share | $1.72 |
| Equity (Book Value) | 168.45M |
| Book Value Per Share | 1.79 |
| Working Capital | 218.21M |
Full Balance SheetCash Flow
| Operating Cash Flow | -92.85M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.02M |
| Net Borrowing | n/a |
| Free Cash Flow | -92.85M |
| FCF Per Share | -$1.02 |
Full Cash Flow StatementMargins
| Gross Margin | 81.82% |
| Operating Margin | -1,006.72% |
| Pretax Margin | -1,106.22% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XFOR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -968.53% |
| Shareholder Yield | -968.53% |
| Earnings Yield | -24.76% |
| FCF Yield | -23.05% |
Analyst Forecast
The average price target for XFOR is $9.00, which is 103.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 103.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 83.31% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 28, 2025. It was a reverse split with a ratio of 1:30.
| Last Split Date | Apr 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
